www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their ...
www.MarketResearchReports.com
Introduction to Report
 Launch Date: March 31, 2014
 Number of Pages: 327
 Geography Cove...
www.MarketResearchReports.com
About the Report
Parkinson’s disease is a progressive condition that is
characterized by bra...
www.MarketResearchReports.com
Research Findings
Global Parkinson’s Disease Therapeutics Market Value to
Reach $5.3 Billio...
www.MarketResearchReports.com
Research Findings Continues..
Population increases, especially in the elderly, will be a ke...
www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Disease Overview
3. Epidemiology
4. Disease Management
5....
www.MarketResearchReports.com
Company Coverage
1. Merck
2. Roche
3. AbbVie
4. UCB
5. GlaxoSmithKline
6. Novartis
7. Orion
...
www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, inves...
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this public...
Upcoming SlideShare
Loading in …5
×

Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

274 views

Published on

Market Research Reports, Inc. has announced the addition of “PharmaPoint: Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022” research report to their offering. See more at- http://mrr.cm/ZQd

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
274
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
43
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Parkinson’s Disease - Global Drug Forecast and Market Analysis to 2022

  1. 1. www.MarketResearchReports.com Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  2. 2. www.MarketResearchReports.com Introduction to Report  Launch Date: March 31, 2014  Number of Pages: 327  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 9,995 Price For Site License: USD 1,990 Price For Global User License: USD 29,985 Delivery Time: Within 24 Hours (During Working Days)
  3. 3. www.MarketResearchReports.com About the Report Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. It is expected that the prevalence of Parkinson’s disease in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and Brazil will increase from 3.2m people in 2012 to 4.3m people in 2022, driven by an aging population in all markets. Dopaminergic therapies have been fairly effective in treating bradykinesia, but several unmet needs remain.
  4. 4. www.MarketResearchReports.com Research Findings Global Parkinson’s Disease Therapeutics Market Value to Reach $5.3 Billion by 2022, as Current Pipeline Addresses Advanced Patients’ Needs, says Publisher As the prevalence of Parkinson’s Disease (PD) continues to grow thanks to an ageing population, its treatment market value is expected to increase from $3.6 billion in 2012 to $5.3 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 4%, says research and consulting firm by Publisher. According to the company’s latest report the US will have the largest PD therapeutics market share of 44% by 2022, expanding from 32% in 2012. This will be followed by Japan, Brazil and Germany, with respective shares of 13%, 11% and 10%.
  5. 5. www.MarketResearchReports.com Research Findings Continues.. Population increases, especially in the elderly, will be a key driving force in the global PD market. With several small biotech and pharmaceutical companies involved in mid-stage development of PD products, there will be ample opportunity for partnerships with Big Pharma. Levodopa based therapy will remain the gold standard of care with advancements in administration, including the introduction of slow-release formulations and an emergency use inhaler. Several unmet needs are expected to remain after the forecast period, as advancements in the control of non-motor symptoms and in the development of disease-modifying therapies are lagging.
  6. 6. www.MarketResearchReports.com Report Coverage 1. Introduction 2. Disease Overview 3. Epidemiology 4. Disease Management 5. Competitive Assessment 6. Opportunity and Unmet Need 7. Pipeline Assessment 8. Current and Future Players 9. Market Outlook 10.Appendix For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  7. 7. www.MarketResearchReports.com Company Coverage 1. Merck 2. Roche 3. AbbVie 4. UCB 5. GlaxoSmithKline 6. Novartis 7. Orion 8. Newron 9. Civitas 10.Impax 11.Lundbeck For more details regarding Report coverage see the last slide All logos and Images mentioned on this slide belong to their respective owners.
  8. 8. www.MarketResearchReports.com Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @ http://www.marketresearchreports.com/idea-center
  9. 9. www.MarketResearchReports.com How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: http://mrr.cm/ZQd About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +1 302-703-7787 (USA) +91-8762746600 (India)

×